Back to search results

Telehealth and Onsite Maintenance Exercise for Chronic Lung Disease

This study is looking at whether supervised exercise programs, delivered either online (Telehealth Maintenance Exercise) or in person (Onsite Maintenance Exercise Training), can help adults with Chronic Lung Disease (like COPD, emphysema, or chronic bronchitis) after they've finished a traditional exercise program. Researchers want to see if these maintenance programs improve things like your ability to exercise, breathing difficulties (dyspnea), physical function, activity levels, and quality of life. You could be assigned to one of three groups: telehealth exercise, onsite exercise, or a control group that doesn't receive the exercise program during the study. The study aims to enroll 30 participants and is currently unclear on its recruitment status.

Study design
This is an interventional study with 30 planned participants. You will be randomly assigned to one of three groups: telehealth exercise, onsite exercise, or a control group.
What's involved
You would participate in an 8-week supervised exercise program, either online or in person, with weekly 60-minute sessions. Your exercise capacity will be measured at the beginning, at 8 weeks, and again at 4 months.
Compensation
Not stated in the trial record.
Follow-up
Your exercise capacity will be measured at 8 weeks (end of the study) and at 4 months after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06304207

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

UNKNOWN
NAAges 40+InterventionalPrevention
MGH Institute of Health Professions
~30 participants
Updated 2024-08-01 on ClinicalTrials.gov
What's tested:Onsite Maintenance Exercise TrainingTelehealth Maintenance Exercise

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Exercise Capacity
Measured over At baseline
+11 more outcomes measured

Conditions

Copd
COPD Exacerbation
COPD Bronchitis
Emphysema or COPD
Chronic Lung Disease
Pulmonary Fibrosis
Interstitial Lung Disease
Bronchiectasis
Chronic Asthma
Chronic Asthmatic Bronchitis

Explore related trials

AsthmaBronchiectasisChronic Lung DisorderChronic Obstructive Pulmonary DiseaseInterstitial Lung DiseasePulmonary Fibrosis

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Shweta Gore, PhD · PRINCIPAL_INVESTIGATOR · MGH Institute of Health Professions

Who to contact

Shweta Gore, PhD
[email protected]
9895256619
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All adult patients 40 years and older with physician diagnosed Chronic Lung Disease within 2 months of discharge following completion of a traditional onsite outpatient rehabilitation or physical therapy or exercise program for their condition
Able to walk independently with or without mobility devices
Able to complete a six-minute walk test at discharge with or without supplemental oxygen maintaining an oxygen saturation at or above 85%
Able to follow commands and instructions in the English language
Have ability to connect to the internet

Exclusion

• Those with significant mobility limitations such as those with a history of stroke, neurological comorbidities such as Parkinson's disease or relapsing multiple sclerosis, or significant degenerative osteoarthritis, or any other joint impairments that compromise ability to walk independently with or without an assistive device.
Patients who primarily rely on a wheelchair for mobility
Patients with or without supplemental oxygen who are unable to complete a walking test without a drop in oxygen saturation to below 85% at discharge from traditional outpatient rehabilitation
Patients with baseline hemodynamic compromise, unstable angina, a recent myocardial infarction within a week, uncontrollable atrial fibrillation not managed with medications, advanced stage heart failure (New York Heart Association class 4), or those with mechanical circulatory assist devices for the heart such a ventricular assist device (VADs)
Inability to communicate in the English language

What this trial measures

  • Exercise CapacityAt baseline

    Exercise capacity as measured by the six-minute walk distance

  • Exercise CapacityAt 8 weeks (end of the study)

    Exercise capacity as measured by the six-minute walk distance

  • Exercise CapacityAt 4 months follow up

    Exercise capacity as measured by the six-minute walk distance

  • DyspneaAt baseline

    Dyspnea measured on the modified Medical Research Council (mMRC) scale score ranges from 0-4 with higher scores indicating greater shortness of breath

  • DyspneaAt 8 weeks (end of the study)

    Dyspnea measured on the modified Medical Research Council (mMRC) scale score ranges from 0-4 with higher scores indicating greater shortness of breath

  • DyspneaAt 4 months follow up

    Dyspnea measured on the modified Medical Research Council (mMRC) scale score ranges from 0-4 with higher scores indicating greater shortness of breath

  • Physical FunctionAt baseline,

    Physical function measured by the 30 seconds chair rise test

  • Physical FunctionAt 8 weeks (end of the study),

    Physical function measured by the 30 seconds chair rise test

  • Physical FunctionAt 4 months follow up

    Physical function measured by the 30 seconds chair rise test

  • Quality of life measureAt baseline

    Quality of life measured by the chronic obstructive pulmonary disease Assessment Test (CAT) scale. Score ranges from 0-40, with higher scores indicating a more severe impact on a patient's life

  • Quality of life measureAt 8 weeks (end of study)

    Quality of life measured by the chronic obstructive pulmonary disease Assessment Test (CAT) scale. Score ranges from 0-40, with higher scores indicating a more severe impact on a patient's life

  • Quality of life measureAt 4- month follow up

    Quality of life measured by the chronic obstructive pulmonary disease Assessment Test (CAT) scale. Score ranges from 0-40, with higher scores indicating a more severe impact on a patient's life